News

• Regeneron to provide 100,000 treatments per month - CEO
  11/23/2020 / 16:53 - TeleTrader
•  
• Gold, silver sink on COVID vaccine optimism
  11/23/2020 / 16:10 - TeleTrader
•  
• Wall Street opens in green on vaccine progress
  11/23/2020 / 15:30 - TeleTrader
•  
• Kiniksa Announces U.S. FDA Acceptance of sBLA and Priority Review for Rilonacept in Recurrent Pericarditis
  11/23/2020 / 14:00 - GlobeNewswire
•  
• Genenta to Appoint Stephen Squinto, Experienced Biotech Executive and Investor, as Chairman
  11/23/2020 / 07:00 - GlobeNewswire
•  
• FDA approves Regeneron COVID-19 treatment
  11/22/2020 / 04:16 - TeleTrader
•  
• Ziopharm Oncology Appoints Raffaele Baffa, M.D., Ph.D., as Chief Medical Officer
  11/17/2020 / 22:15 - GlobeNewswire
•  
• Kiniksa Announces New England Journal of Medicine Publication of Rilonacept Phase 3 Data in Recurrent Pericarditis and Late-Breaking Science Presentation at American Heart Association Scientific Sessions 2020
  11/17/2020 / 14:00 - GlobeNewswire
•  
• Ziopharm Oncology Appoints Mary Thistle to Board of Directors
  11/16/2020 / 14:30 - GlobeNewswire
•  
• Intellia Therapeutics Doses First Patient in Landmark CRISPR/Cas9 Clinical Trial of NTLA-2001 for the Treatment of Transthyretin Amyloidosis
  11/09/2020 / 13:30 - GlobeNewswire
•  
• Coherus BioSciences Reports Third Quarter 2020 Financial Results
  11/05/2020 / 22:02 - GlobeNewswire
•  
• Kiniksa Reports Third Quarter 2020 Financial Results and Highlights Recent Pipeline and Corporate Activity
  11/05/2020 / 13:30 - GlobeNewswire
•  
• Intellia Therapeutics Announces Third Quarter 2020 Financial Results
  11/05/2020 / 13:30 - GlobeNewswire
•  
• Regeneron posts Q3 revenue at $2.3B, up 32% YoY
  11/05/2020 / 13:16 - TeleTrader
•  
• CRISPR-Focused Excision BioTherapeutics Announces Business Advisory Board and Addition of Interim Chief Business Officer
  11/03/2020 / 15:00 - GlobeNewswire